EDGAR Filing Documents for 0000898432-12-000417

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0000898432-12-000417

Filing Date

2012-03-30

Accepted

2012-03-30 12:44:33

Documents

Effectiveness Date

2012-03-30

Items

Item 06: Rule 506
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	7126
	Complete submission text file	0000898432-12-000417.txt		8298

Mailing Address 1212 AVENUE OF THE AMERICAS 19TH FLOOR NEW YORK NY 10036

Business Address 1212 AVENUE OF THE AMERICAS 19TH FLOOR NEW YORK NY 10036 212-798-1360

Genesis Life Sciences Fund LP (Filer) CIK: 0001545731 (see all company filings)